Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q2- Text added to 2017 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
abatement, absence, accredited, agonist, Allergan, ballot, bipartisan, broaden, Brown, chamber, circumvent, CSR, esaxerenone, exemption, family, framework, fullest, Governor, Holdco, hormone, implicated, inverse, IRRC, Jerry, judicial, justification, laboratory, led, mandated, Master, month, mutant, nuclear, occupying, Ohio, PDUFA, Priority, retinoic, Shield, smaller, steadfast, threatened, threshold, transferee, UK, vacated, variation, wild
Valuein 2017 Q2 filing- Value in 2017 Q3 filing
Original filings
Filing view